Results 251 to 260 of about 67,878 (296)
Some of the next articles are maybe not open access.

Thalidomide

BioDrugs, 1999
The major therapeutic effects of thalidomide are the selective inhibition of tumour necrosis factor-alpha production by monocytes and alteration in cellular surface expression of integrins. The major drawbacks of the drug are teratogenicity and irreversible axonal neuropathy.
openaire   +2 more sources

Thalidomide

Reactions Weekly, 2018
In 1962, the United States found itself transfixed by a crisis involving the medication thalidomide. Marketed widely in Europe for a variety of ailments, including nausea during pregnancy, thalidomide turned out to be a severe teratogen, causing thousands of severe birth defects in Germany alone. Yet as a result of diligence by the U.S.
openaire   +2 more sources

Thalidomide

Annales de Dermatologie et de Vénéréologie, 2007
E, Laffitte, J, Revuz
openaire   +3 more sources

Thalidomide

Reactions Weekly, 2006
James L. Schardein, Orest T. Macina
  +4 more sources

Thalidomide Embryopathy

Archives of Environmental Health: An International Journal, 1962
W, LENZ, K, KNAPP
openaire   +3 more sources

Thalidomide solution

American Journal of Obstetrics and Gynecology, 1968
D A, Blake, C A, Fleischer, R L, Wynn
openaire   +2 more sources

Thalidomide Solutions

Science, 1966
H, Schumacher, D, Blake, J, Gillette
openaire   +2 more sources

Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders

Chemical Society Reviews, 2022
Junichi Yamamoto   +2 more
exaly  

Thalidomide

International Journal of Dermatology, 1981
openaire   +2 more sources

Home - About - Disclaimer - Privacy